Molecular mechanism of the vascular endothelial growth factor and its receptors in the genesis of hematological malignanices
LIANG Ai-Bin
Abstract No abstract available
Cite this article:
LIANG Ai-Bin. Molecular mechanism of the vascular endothelial growth factor and its receptors in the genesis of hematological malignanices[J]. 中国当代儿科杂志, 2002, 4(5): 427-430.
LIANG Ai-Bin. Molecular mechanism of the vascular endothelial growth factor and its receptors in the genesis of hematological malignanices[J]. CJCP, 2002, 4(5): 427-430.
URL:
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2002/V4/I5/427
[1]
GU Jiao-Wei, HU Zhong-Dong, LIU Zhuang. Correlation between the ratio of serum vascular endothelial growth factor/endostatin and childhood acute leukemia [J]. 中国当代儿科杂志, 2011, 13(6): 475-477.
[2]
WU Sheng-Hua, CHEN Hui, TANG Yun-Zhang. A case report of subcutaneous paniculitis-like T-cell hyperplasia [J]. 中国当代儿科杂志, 2007, 9(5): 501-502.
[3]
ZHANG Jin-Feng, HUANG Rong. Renal tubular acidosis as an initial manifestation in children with malignant lymphoma [J]. 中国当代儿科杂志, 2008, 10(4): 500-503.
[4]
FENG Li-Juan, ZHANG Guo-Ping, XIE Min, CAO Peng-Fei, FU Chun-Yan, HU Zhong-Liang, DAI Mao. Relationship between p53 gene and chromosome 13q14 variations and prognosis in primary intestinal lymphoma [J]. 中国当代儿科杂志, 2009, 11(07): 555-558.
[5]
LI Hai-Ying, WANG Huai-Li, GAO Tie-Zheng, ZHUO Zhi-Hong, LI Dao-Ming, LI Hui-Xiang. Hydroa vacciniforme-like cutaneous T cell lymphoma: a case report and literature review [J]. 中国当代儿科杂志, 2009, 11(07): 596-598.
[6]
XIE Jing, ZHANG Da-Wei, YANG Shuang, WU Min-Yuan. Diagnosis and treatment of childhood hemophagocytic lymphohistiocytosis: experience of 28 cases [J]. 中国当代儿科杂志, 2006, 8(4): 345-347.
[7]
LIANG Ai-Bin. Molecular mechanism of the vascular endothelial growth factor and its receptors in the genesis of hematological malignanices [J]. 中国当代儿科杂志, 2002, 4(5): 427-430.
[8]
ZHANG Jing-Rong, ZHANG Guo-Yuan. Clinical analysis of 13 cases of primary extralymphnodal lymphoma [J]. 中国当代儿科杂志, 2001, 3(1): 93-94.